CHOLESTYRAMINE Side Effects

6955372-0 | Confusional State, Diarrhoea, Hypersensitivity, Lethargy
on Sep 18, 2009 Female patient from UNITED STATES , 66 years of age, weighting 220.0 lb, was diagnosed with blood cholesterol increased, blood pressure increased, hypertension, gastrooesophageal reflux disease and was treated with Cholestyramine (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, diarrhoea, hypersensitivity, lethargy. Cholestyramine dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PROTONIX (View Protonix Review and Protonix Label ).

6915198-0 | Small Intestinal Obstruction
Patient was taking Cholestyramine (View Usage). Patient had the following side effects: small intestinal obstruction on Aug 05, 2010 from UNITED STATES Additional patient health information: Male patient , 84 years of age, weighting 156.7 lb, was diagnosed with faecal incontinence and. Cholestyramine dosage: 4 Gm Every Day Po. Patient was hospitalized.

6796291-2 | Product Odour Abnormal
Adverse event was reported on Jun 24, 2010 by a Male patient taking Cholestyramine (View Usage) (Dosage: Mix And Drink 10 Packets Daily) . Location: UNITED STATES , 61 years of age, After Cholestyramine was administered, patient had the following side effects: product odour abnormal.

6611269-7 | Gingival Swelling, Swollen Tongue, Tongue Ulceration
on Mar 01, 2010 Female patient from UNITED STATES , weighting 130.0 lb, was treated with Cholestyramine (View Usage). Patient experienced the following unwanted or unexpected effects: gingival swelling, swollen tongue, tongue ulceration. Cholestyramine dosage: 4gm 1x Per Day Po.


6596512-5 | Gastrointestinal Haemorrhage, Haemoglobin Decreased, Rectal Haemorrhage
on Feb 22, 2010 Male patient from UNITED STATES , 86 years of age, weighting 201.1 lb, was diagnosed with hyperlipidaemia and was treated with Cholestyramine (View Usage). Patient had the following side effects: gastrointestinal haemorrhage, haemoglobin decreased, rectal haemorrhage. Cholestyramine dosage: 1 Scoop Bid Po.

6575329-1 | Burning Sensation, Glossitis, Oedema Mouth, Stomatitis, Swollen Tongue
Patient was taking Cholestyramine (View Usage). After Cholestyramine was administered, patient had the following side effects: burning sensation, glossitis, oedema mouth, stomatitis, swollen tongue on Feb 08, 2010 from UNITED STATES Additional patient health information: Female patient , 74 years of age, weighting 125.0 lb, was diagnosed with gastrointestinal disorder and. Cholestyramine dosage: 4 Gram Scoopful Bedtime.

6505298-1 | Hyperglycaemia
Adverse event was reported on Jun 30, 2009 by a Female patient taking Cholestyramine (View Usage) (Dosage: Suspension) . Location: UNITED STATES , 48 years of age, Patient experienced the following unwanted or unexpected effects: hyperglycaemia.

6499883-3 | Anxiety, Diarrhoea, Product Solubility Abnormal
on Dec 14, 2009 Male patient from UNITED STATES , 73 years of age, weighting 190.0 lb, was diagnosed with crohn's disease (What is crohn's disease?), diarrhoea and was treated with Cholestyramine (View Usage). Patient had the following side effects: anxiety (What is anxiety?), diarrhoea, product solubility abnormal. Cholestyramine dosage: 3/4 Scoop With 8oz Juice Or Wat Daily At Bedtime.

6431468-7 | Flatulence, Social Problem, Unevaluable Event, Weight Decreased
on Nov 05, 2009 Female patient from UNITED STATES , 52 years of age, weighting 135.0 lb, was treated with Cholestyramine (View Usage). After Cholestyramine was administered, patient had the following side effects: flatulence, social problem, unevaluable event, weight decreased. Cholestyramine dosage: Directions On Box.

6377277-9 | Hepatic Enzyme Abnormal
Patient was taking Cholestyramine (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic enzyme abnormal on Sep 24, 2009 from UNITED STATES Additional patient health information: Male patient , 61 years of age, weighting 258.0 lb, was diagnosed with hyperlipidaemia and. Cholestyramine dosage: 4 Gm Bid Po.

6262823-6 | Hyperglycaemia
Adverse event was reported on Jun 26, 2009 by a Female patient taking Cholestyramine (View Usage) (Dosage: 1 Df Qd, In The Morning, Oral) . Location: UNITED STATES , 48 years of age, Patient had the following side effects: hyperglycaemia.

6168802-1 | Drooling
on Apr 24, 2009 Male patient from UNITED STATES , 63 years of age, weighting 188.0 lb, was diagnosed with hyperlipidaemia and was treated with Cholestyramine (View Usage). After Cholestyramine was administered, patient had the following side effects: drooling. Cholestyramine dosage: 4 Gm Bid Po.

6146239-9 | Muscular Weakness, Neuropathy Peripheral, Product Quality Issue
on Mar 23, 2009 Male patient from UNITED STATES , weighting 280.0 lb, was diagnosed with blood cholesterol increased and was treated with Cholestyramine (View Usage). Patient experienced the following unwanted or unexpected effects: muscular weakness, neuropathy peripheral, product quality issue. Cholestyramine dosage: 2 Df Bid, At Lunch And Supper, Oral. During the same period patient was treated with QUESTRAN (Df Oral) (View Questran Review and Questran Label ), METOPROLOL IMMEDIATE RELEASE (View Metoprolol Immediate Release Review and Metoprolol Immediate Release Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6124349-X | Abdominal Discomfort
Patient was taking Cholestyramine (View Usage). Patient had the following side effects: abdominal discomfort on Mar 18, 2009 from UNITED STATES Additional patient health information: Male patient , 56 years of age, weighting 140.0 lb, . Cholestyramine dosage: 1 Tab Twice Po.

6060223-5 | Cholestasis, Hepatitis Fulminant, Hepatotoxicity, Serum Ferritin Increased, Vitamin K Deficiency
Adverse event was reported on Jan 21, 2009 by a Female patient taking Cholestyramine (View Usage) (Dosage: 8 G Tid) was diagnosed with hepatitis (What is hepatitis?), still's disease adult onset and. Location: FRANCE , 34 years of age, After Cholestyramine was administered, patient had the following side effects: cholestasis, hepatitis fulminant, hepatotoxicity, serum ferritin increased, vitamin k deficiency. During the same period patient was treated with LEFLUNOMIDE (20 Mg) (View Leflunomide Review and Leflunomide Label ), ACETAMINOPHEN WITH PROPOXYPHENE HCL TAB (View Acetaminophen With Propoxyphene Hcl Tab Review and Acetaminophen With Propoxyphene Hcl Tab Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ), CANDESARTAN (View Candesartan Review and Candesartan Label ), CALCIUM CARBONATE W/COLECALCIFEROL (View Calcium Carbonate W/colecalciferol Review and Calcium Carbonate W/colecalciferol Label ). Patient was hospitalized.

6012883-2 | Acidosis Hyperchloraemic, Blood Bicarbonate Decreased, Blood Chloride Increased, Blood Creatinine Increased, Blood Potassium Increased
on Dec 15, 2008 Male patient from CHINA , 45 years of age, was treated with Cholestyramine (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis hyperchloraemic, blood bicarbonate decreased, blood chloride increased, blood creatinine increased, blood potassium increased. Cholestyramine dosage: . During the same period patient was treated with ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), FRUSEMIDE (View Frusemide Review and Frusemide Label ), METHYLDOPA (View Methyldopa Review and Methyldopa Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6006593-5 | Acidosis Hyperchloraemic, Diarrhoea, Hypernatraemia, Pyrexia, Vomiting
on Dec 12, 2008 Male patient from UNITED STATES , weighting 11.02 lb, was diagnosed with hepatitis neonatal and was treated with Cholestyramine (View Usage). Patient had the following side effects: acidosis hyperchloraemic, diarrhoea, hypernatraemia, pyrexia, vomiting. Cholestyramine dosage: 20 To 24 Gm Of The Cholestyramine Resin Daily In 1000 To 1200 Ml Of Portagen Products.. During the same period patient was treated with PORTAGEN (1 Dosage Form = 1000-1200ml.) (View Portagen Review and Portagen Label ). Patient was hospitalized.

6006592-3 | Diarrhoea, Hyperchloraemia, Hypernatraemia, Vomiting
Patient was taking Cholestyramine (View Usage). After Cholestyramine was administered, patient had the following side effects: diarrhoea, hyperchloraemia, hypernatraemia, vomiting on Dec 12, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 8.82 lb, was diagnosed with congenital absence of bile ducts and. Cholestyramine dosage: . During the same period patient was treated with PORTAGEN (1 Dosage Form = 1000-1200ml.) (View Portagen Review and Portagen Label ). Patient was hospitalized.

6000999-6 | Dyspnoea, Gastrointestinal Disorder, Therapeutic Response Decreased
Adverse event was reported on Apr 01, 2008 by a Female patient taking Cholestyramine (View Usage) (Dosage: Oral Suspension) . Location: UNITED STATES , 62 years of age, Patient experienced the following unwanted or unexpected effects: dyspnoea, gastrointestinal disorder, therapeutic response decreased.

6000995-9 | Hypersensitivity
on Jan 10, 2008 Male patient from UNITED STATES , 49 years of age, weighting 169.8 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Cholestyramine (View Usage). Patient had the following side effects: hypersensitivity. Cholestyramine dosage: . During the same period patient was treated with PENTASA (View Pentasa Review and Pentasa Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ).

6000994-7 | Dizziness, Nausea
on Jan 10, 2008 Female patient from UNITED STATES , 61 years of age, weighting 134.5 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Cholestyramine (View Usage). After Cholestyramine was administered, patient had the following side effects: dizziness (What is dizziness?), nausea (What is nausea?). Cholestyramine dosage: 1 Dosage Form = 1 Dose. During the same period patient was treated with LEFLUNOMIDE (10 Mg Po From Feb-2007 To June-2007.) (View Leflunomide Review and Leflunomide Label ).

5999964-4 | Aortic Thrombosis, International Normalised Ratio Decreased
Patient was taking Cholestyramine (View Usage). Patient experienced the following unwanted or unexpected effects: aortic thrombosis, international normalised ratio decreased on Dec 10, 2008 from SWITZERLAND Additional patient health information: Female patient , 65 years of age, was diagnosed with hypercholesterolaemia and. Cholestyramine dosage: . During the same period patient was treated with PHENPROCOUMON (View Phenprocoumon Review and Phenprocoumon Label ). Patient was hospitalized.

5807526-4 | Flushing, Rash
Adverse event was reported on Jul 09, 2008 by a Male patient taking Cholestyramine (View Usage) (Dosage: 4 Gm Bid Po) was diagnosed with hyperlipidaemia, hypertension and. Location: UNITED STATES , 76 years of age, weighting 213.0 lb, Patient had the following side effects: flushing, rash (What is rash?). During the same period patient was treated with LISINOPRIL (5 Mg Every Day Po) (View Lisinopril Review and Lisinopril Label ).

5794556-4 | Aspiration, Aspiration Tracheal, Bezoar, Intestinal Obstruction, Mechanical Ventilation, Respiratory Distress
on Jun 17, 2008 Female patient from FRANCE , 79 years of age, was diagnosed with pruritus, prophylaxis, upper gastrointestinal haemorrhage and was treated with Cholestyramine (View Usage). After Cholestyramine was administered, patient had the following side effects: aspiration, aspiration tracheal, bezoar, intestinal obstruction, mechanical ventilation, respiratory distress. Cholestyramine dosage: 4 G/ Day, Oral. During the same period patient was treated with OMEPRAZOLE (20 Mg/ Day) (View Omeprazole Review and Omeprazole Label ), LACTULOSE (View Lactulose Review and Lactulose Label ). Patient was hospitalized.

5776669-6 | Aspiration, Aspiration Tracheal, Bezoar, Flatulence, Impaired Gastric Emptying, Intestinal Obstruction, Respiratory Distress, Upper Gastrointestinal Haemorrhage
on May 28, 2008 Female patient from FRANCE , 79 years of age, was diagnosed with prophylaxis, upper gastrointestinal haemorrhage and was treated with Cholestyramine (View Usage). Patient experienced the following unwanted or unexpected effects: aspiration, aspiration tracheal, bezoar, flatulence, impaired gastric emptying, intestinal obstruction, respiratory distress, upper gastrointestinal haemorrhage. Cholestyramine dosage: 4 G/day, Oral. During the same period patient was treated with OMEPRAZOLE (20 Mg Day) (View Omeprazole Review and Omeprazole Label ), LACTULOSE (View Lactulose Review and Lactulose Label ). Patient was hospitalized.

5591425-X | Eye Swelling
Patient was taking Cholestyramine (View Usage). Patient had the following side effects: eye swelling on Jan 11, 2008 from UNITED STATES Additional patient health information: Male patient , 67 years of age, weighting 218.3 lb, was diagnosed with hyperlipidaemia and. Cholestyramine dosage: 4gm Every Day Po.

5519975-2 | Constipation
Adverse event was reported on Sep 28, 2007 by a Female patient taking Cholestyramine (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 141.1 lb, After Cholestyramine was administered, patient had the following side effects: constipation (What is constipation?).

5519965-X | Rash
on Dec 05, 2006 Female patient from UNITED STATES , 64 years of age, was treated with Cholestyramine (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?). Cholestyramine dosage: .

5466952-6 | Gastrointestinal Disorder
on Sep 21, 2007 Female patient from UNITED STATES , 75 years of age, weighting 160.0 lb, was diagnosed with malabsorption and was treated with Cholestyramine (View Usage). Patient had the following side effects: gastrointestinal disorder. Cholestyramine dosage: Orally, 1/2 Scoopful Mixed In Liquid And Drink Daily.

5150241-3 | Abdominal Distension, Flatulence, Food Interaction
Patient was taking Cholestyramine (View Usage). After Cholestyramine was administered, patient had the following side effects: abdominal distension, flatulence, food interaction on Nov 09, 2006 from UNITED STATES Additional patient health information: Male patient , 42 years of age, weighting 150.0 lb, was diagnosed with ileectomy, malabsorption and. Cholestyramine dosage: 1/2 Package Tid Po.

4953662-4 | Anxiety, Arteriosclerosis, Bacterial Infection, Blood Cholesterol Increased, Blood Triglycerides Increased, Cerebrovascular Accident, Constipation, Cough, Depression
Adverse event was reported on Nov 23, 2005 by a Female patient taking Cholestyramine (View Usage) (Dosage: ) . Location: UNITED STATES , 64 years of age, weighting 209.4 lb, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), arteriosclerosis, bacterial infection (What is bacterial infection?), blood cholesterol increased, blood triglycerides increased, cerebrovascular accident, constipation (What is constipation?), cough, depression (What is depression?). During the same period patient was treated with CLARINEX (View Clarinex Review and Clarinex Label ), CLARITIN (View Claritin Review and Claritin Label ), DICYCLOMINE HYDROCHLORIDE (View Dicyclomine Hydrochloride Review and Dicyclomine Hydrochloride Label ), DIPHENOXYLATE (View Diphenoxylate Review and Diphenoxylate Label ), DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), EFFEXOR (View Effexor Review and Effexor Label ), ENDOCET (View Endocet Review and Endocet Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ). Patient was hospitalized.

4911879-9 | Rectal Haemorrhage
on Feb 13, 2006 Male patient from UNITED STATES , 55 years of age, weighting 235.0 lb, was diagnosed with weight control (What is weight control?) and was treated with Cholestyramine (View Usage). Patient had the following side effects: rectal haemorrhage. Cholestyramine dosage: 1 Foil Pkg 1 Day Mouth. During the same period patient was treated with XENICAL (1/3 Of Capsule 2 X Day Mouth) (View Xenical Review and Xenical Label ).

4850663-1 | Dry Throat, Eye Pruritus
on Oct 10, 2005 Female patient from UNITED STATES , 72 years of age, weighting 189.6 lb, was diagnosed with diarrhoea and was treated with Cholestyramine (View Usage). After Cholestyramine was administered, patient had the following side effects: dry throat, eye pruritus. Cholestyramine dosage: Dosage Form = 1 Scope. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), EVISTA (View Evista Review and Evista Label ), ATENOLOL (View Atenolol Review and Atenolol Label ).

4850660-6 | Constipation
Patient was taking Cholestyramine (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?) on Jun 28, 2005 from UNITED STATES Additional patient health information: Female patient , 80 years of age, weighting 114.6 lb, was diagnosed with blood cholesterol increased and. Cholestyramine dosage: .

4850654-0 | Abdominal Pain, Constipation, Cough, Diarrhoea
Adverse event was reported on Mar 21, 2005 by a Female patient taking Cholestyramine (View Usage) (Dosage: ) was diagnosed with blood cholesterol increased and. Location: UNITED STATES , 51 years of age, weighting 167.6 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), constipation (What is constipation?), cough, diarrhoea. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), CELEXA (View Celexa Review and Celexa Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ).

4850653-9 | Constipation
on Feb 28, 2005 Female patient from UNITED STATES , 80 years of age, weighting 114.6 lb, was diagnosed with hyperlipidaemia and was treated with Cholestyramine (View Usage). After Cholestyramine was administered, patient had the following side effects: constipation (What is constipation?). Cholestyramine dosage: . During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ).

4803229-3 | Diarrhoea, Rash, Viral Infection, Vomiting
on May 05, 2003 Female patient from UNITED STATES , 36 years of age, was diagnosed with blood bilirubin decreased and was treated with Cholestyramine (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, rash (What is rash?), viral infection (What is viral infection?), vomiting. Cholestyramine dosage: 1 Scoop Po Tid. During the same period patient was treated with DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), POTASSIUM (View Potassium Review and Potassium Label ), AMINO ACIDS (View Amino Acids Review and Amino Acids Label ). Patient was hospitalized.

4803223-2 | Convulsion, Epilepsy, Nausea
Patient was taking Cholestyramine (View Usage). Patient had the following side effects: convulsion, epilepsy (What is epilepsy?), nausea (What is nausea?) on Sep 18, 2002 from UNITED STATES Additional patient health information: Female patient , 63 years of age, weighting 150.0 lb, was diagnosed with gastrointestinal disorder and. Cholestyramine dosage: 1 Scoop Po Bid. During the same period patient was treated with DILANTIN (View Dilantin Review and Dilantin Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ).